How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview

Overview of attention for article published in Advances in Therapy, May 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,431 followers.

RT @retina_papers: How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A System…

27 May 2019

Reply Repost Favourite

How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview. https://t.co/ykKY4JcpIx

22 May 2019

Reply Repost Favourite

New #review article asks the question: how successful is switching from bevacizumab or ranibizumab to aflibercept in age-related macular degeneration? https://t.co/ZcAFRFKCtn #openaccess #retina #ophthalmology https://t.co/ZC1k8LMEee

17 May 2019

Reply Repost Favourite